Search
for
Sort by
Research 631–660 of 1000+
- Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
- Alopecia Areata
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- SnapshotDx Quiz: January 2021
- Dermal EZH2 simultaneously orchestrates dermal differentiation and epidermal proliferation during murine skin development
- SnapshotDx Quiz: February 2018
- SnapshotDx Quiz: May 2022
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- A bibliometric analysis of trends in the application of platelet‐rich plasma in cosmetics research between 2001 and 2022
- The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
- Controlled Release of Minoxidil through Hydrogel Cross-Linking to Treat Androgenetic Alopecia
- Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
- Expression of ΔNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
- A Retrospective Study on Alopecia Areata in Children: Clinical Characteristics and Treatment Choices
- Folliculotropic mycosis fungoides complicated by eosinophilia: a case report
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Minoxidil-induced hypertrichosis in a child with alopecia areata
- <i>In vivo</i> response of GsdmA3<sup>Dfl</sup>/+ mice to topically applied fish oil – effects on cellular markers and macrophages